TCT CONNECT-282 Incidence and Temporal Volumetric Change in Coronary Evagination After Implantation of Bioresorbable Polymer Sirolimus-Eluting Stent: An Mechanism-Ultimaster Substudy
نویسندگان
چکیده
منابع مشابه
Protruding In-Stent Mass After Bioresorbable Polymer Sirolimus-Eluting Stent - Ex Vivo Intravascular Imaging and Histopathology.
(Figure 1C). After perfusion fixation of the heart under the normal diastolic pressure by 10% buffered formalin for 24 h, epicardial coronary arteries were removed from the heart. The whole stent segment was embedded in plastic (Technovit 8100; Heraeus Kulzer, Wehrheim, Germany) with the stent struts. Histological sections stained by hematoxylin-eosin and Masson’s trichrome showed a convex mass...
متن کاملThe Ultimaster Biodegradable-Polymer Sirolimus-Eluting Stent: An Updated Review of Clinical Evidence
The Ultimaster coronary stent system (Terumo Corporation, Tokyo, Japan) represents a new iteration in drug-eluting stent (DES) technology that has recently received the Conformité Européenne (CE) mark approval for clinical use. The Ultimaster is a thin-strut, cobalt chromium, biodegradable-polymer, sirolimus-eluting coronary stent. The high elasticity of the biodegradable-polymer (PDLLA-PCL) an...
متن کاملZotarolimus - eluting versus sirolimus - eluting coronary stent implantation review
The safety and efficacy of coronary stents, utilized for treatment of ischemic heart disease, have been evaluated extensively. In comparison with bare-metal stents, first-generation drug-eluting stents more than halved the need for target lesion revascularization, but long-term safety has been questioned, as the first-generation drug-eluting stents seem to be associated with a small, but increa...
متن کاملAntiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation.
BACKGROUND The influences of antiplatelet therapy discontinuation on the risk of stent thrombosis and long-term clinical outcomes after drug-eluting stent implantation have not yet been addressed adequately. METHODS AND RESULTS In an observational study in Japan, 2-year outcomes were assessed in 10 778 patients undergoing sirolimus-eluting stent implantation. Data on status of antiplatelet th...
متن کاملStent thrombosis after successful sirolimus-eluting stent implantation.
BACKGROUND Stent thrombosis (ST) is a rare but devastating complication of coronary stent implantation, occurring in 0.5% to 1.9% of patients with bare metal stents. The incidence of ST with drug-eluting stents is less well studied, particularly among patients outside of clinical trials. METHODS AND RESULTS The aim of this study was to evaluate the incidence and potential risk factors for ST ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the American College of Cardiology
سال: 2020
ISSN: 0735-1097
DOI: 10.1016/j.jacc.2020.09.299